Prevention and treatment of cryptosporidiosis in immunocompromised patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Prevention and Treatment of Cryptosporidiosis in Immunocompromised Patients." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440259/all/Prevention_and_treatment_of_cryptosporidiosis_in_immunocompromised_patients.
Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440259/all/Prevention_and_treatment_of_cryptosporidiosis_in_immunocompromised_patients. Accessed February 8, 2026.
Prevention and treatment of cryptosporidiosis in immunocompromised patients. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440259/all/Prevention_and_treatment_of_cryptosporidiosis_in_immunocompromised_patients
Prevention and Treatment of Cryptosporidiosis in Immunocompromised Patients [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440259/all/Prevention_and_treatment_of_cryptosporidiosis_in_immunocompromised_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Prevention and treatment of cryptosporidiosis in immunocompromised patients
ID - 440259
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440259/all/Prevention_and_treatment_of_cryptosporidiosis_in_immunocompromised_patients
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

